Your browser doesn't support javascript.
loading
Robot-Assisted Partial Cystectomy versus Open Partial Cystectomy for Patients with Urachal Cancer.
Stokkel, Laura E; van de Kamp, Maaike W; Schaake, Eva E; Boellaard, Thierry Nicolas; Hendricksen, Kees; van Rhijn, Bas W G; Mertens, Laura S.
Afiliação
  • Stokkel LE; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van de Kamp MW; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schaake EE; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Boellaard TN; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hendricksen K; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Rhijn BWG; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mertens LS; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
Urol Int ; 106(8): 840-847, 2022.
Article em En | MEDLINE | ID: mdl-35134799
ABSTRACT

INTRODUCTION:

Localized urachal cancer (UrC) can be treated with an open partial cystectomy (OPC) with en bloc resection of the urachal remnant and umbilicus. Robot-assisted partial cystectomy (RAPC) is an alternative approach, of which its safety and efficacy for UrC remains to be determined. In the present study, we analyze these outcomes after RAPC, compared with OPC.

METHODS:

We retrospectively evaluated 55 cN0M0 UrC patients who underwent RAPC (n = 8) or OPC (n = 47) between 1994 and 2020. Overall survival (OS) and recurrence-free survival (RFS) were assessed using Kaplan-Meier methods. Positive surgical margins (PSM), port-site recurrences (PSR) versus wound recurrences were compared. Complications were recorded using the Clavien-Dindo classification.

RESULTS:

Median follow-up was 40 months (IQR 21-95). Two-year OS and RFS for RAPC were 73% (95% confidence intervals (CI); 56-89 months) and 60% (95% CI; 42-78 months), respectively, versus 90% (95% CI; 85-95 months) and 66% (95% CI; 59-73 months) for OPC. PSM rate was 13% in both groups. PSR occurred in 2/8 (25%) patients after RAPC. No wound recurrences occurred after OPC. Postoperative complications occurred in 2/8 (25%) patients after RAPC, versus 5/47 (11%) after OPC (p = 0.27).

CONCLUSION:

Both RAPC and OPC seem feasible surgical modalities to treat localized UrC with comparable survival. The PSR rate of 25% after RAPC should prompt us to be cautious to recommend RAPC as no such recurrences were seen using OPC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Robótica / Procedimentos Cirúrgicos Robóticos Tipo de estudo: Etiology_studies / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Robótica / Procedimentos Cirúrgicos Robóticos Tipo de estudo: Etiology_studies / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article